AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Blinklab Ltd

0.360

+0.000

Volume:- -

Turnover:- -

Market Cap:35.78M

PE:-8.05

High:0.360

Open:0.360

Low:0.360

Close:0.360

Loading ...

Overview Company News Filings

BRIEF-Blinklab Ltd Seeks Trading Halt

Is BlinkLab (ASX:BB1) In A Good Position To Deliver On Growth Plans?

Simply Wall St.

BlinkLab Passes Halfway Point in Patient Recruitment for Initial Phase of US Autism Diagnostic Trial

MT Newswires Live

BRIEF-BlinkLab Seeks Trading Halt

Blinklab - Seeks Trading Halt Pending Announcement on Update Regarding Recruitment for FDA Regulatory Study

THOMSON REUTERS

When Will BlinkLab Limited (ASX:BB1) Turn A Profit?

Simply Wall St.

BlinkLab Completes First Patient Testing in Ohio Trial; Shares Up 7%

MT Newswires Live

BlinkLab Limited's (ASX:BB1) Path To Profitability

Simply Wall St.

BlinkLab Says North Shore Pediatric Therapy Joins Clinical Study

MT Newswires Live

ASX Midday Sector Update: Materials Sector Upbeat, Healthcare Stocks Struggle

MT Newswires Live

BlinkLab Brings First Clinical Site on Board for Autism Diagnostic Registrational Trial, Shares Rise 10%

MT Newswires Live

We're Not Very Worried About BlinkLab's (ASX:BB1) Cash Burn Rate

Simply Wall St.

BRIEF-BlinkLab Ltd Seeks Trading Halt

Blinklab Ltd-Trading Halt

THOMSON REUTERS

BRIEF-BlinkLab Seeks Trading Halt

Blinklab Ltd - Trading Halt Pending Announcement on Autism Study Results

THOMSON REUTERS

ASX Market Update: Index retreats as Min Res takes a dive | Novemebr 13, 2024

The Market Herald

BlinkLab teams up with Monash to trial tech in autism, ADHD study

The Market Herald

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BB1.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BB1.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BB1.AU\",,,,,undefined,":{"symbol":"BB1.AU","market":"AU","secType":"STK","nameCN":"Blinklab Ltd","latestPrice":0.36,"timestamp":1745993520000,"preClose":0.36,"halted":3,"volume":0,"delay":0,"nameEN":"Blinklab Ltd","floatShares":38575040,"shares":99375003,"eps":-0.044698,"marketStatus":"Halted","change":0,"latestTime":"04-30 16:12:00 AEST","open":0.36,"high":0.36,"low":0.36,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.044698,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":0,"adr":0,"listingDate":1712149200000,"exchange":"ASX","adjPreClose":0.36,"openAndCloseTimeList":[[1745971200000,1745992800000]],"volumeRatio":0,"lotSize":0,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BB1.AU\",,,,,undefined,":{"symbol":"BB1.AU","floatShares":38575040,"roa":"-70.87%","roe":"-130.35%","lyrEps":-0.026093,"shares":99375003,"dividePrice":0,"high":0.36,"amplitude":0,"preClose":0.36,"low":0.36,"week52Low":0.205,"pbRate":"7.68","psRate":"183.58","week52High":0.48,"institutionHeld":0,"latestPrice":0.36,"eps":-0.044698,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.044698,"open":0.36,"prevYearClose":0.28,"prevWeekClose":0.36,"prevMonthClose":0.36,"prevQuarterClose":0.385,"fiveDayClose":0.345,"twentyDayClose":0.385,"sixtyDayClose":0.265},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BB1.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531960122","title":"BRIEF-Blinklab Ltd Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2531960122","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531960122?lang=en_us&edition=fundamental","pubTime":"2025-04-29 07:35","pubTimestamp":1745883319,"startTime":"0","endTime":"0","summary":"BRIEF-Blinklab Ltd Seeks Trading HaltApril 29 (Reuters) - BlinkLab Ltd BB1.AX:SEEKS TRADING HALT PENDING ANNOUNCEMENT ON CAPITAL RAISINGFurther company coverage: BB1.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nFWN3R62DD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BB1.AU","BK7094"],"gpt_icon":0},{"id":"2526992826","title":"Is BlinkLab (ASX:BB1) In A Good Position To Deliver On Growth Plans?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526992826","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526992826?lang=en_us&edition=fundamental","pubTime":"2025-04-09 05:11","pubTimestamp":1744146718,"startTime":"0","endTime":"0","summary":"There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly.Given this risk, we thought we'd take a look at whether BlinkLab  shareholders should be worried about its cash burn. In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/blinklab-asx-bb1-good-position-211158812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7094","BB1.AU"],"gpt_icon":0},{"id":"2524804911","title":"BlinkLab Passes Halfway Point in Patient Recruitment for Initial Phase of US Autism Diagnostic Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2524804911","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524804911?lang=en_us&edition=fundamental","pubTime":"2025-04-01 11:03","pubTimestamp":1743476639,"startTime":"0","endTime":"0","summary":"BlinkLab  recruited 54 out of 100 children for the initial phase of its US autism diagnostic clinical trial, according to a Tuesday filing with the Australian bourse.The study aims to validate the BlinkLab Dx1 neurological test as a diagnostic aid for clinicians in early assessment of developmental disorders, the filing said.The company is expected to complete enrolment and data analysis of the initial study by the third quarter of the year, per the filing.Shares fell past 1% in afternoon trade Tuesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BB1.AU","BK7094"],"gpt_icon":0},{"id":"2523930964","title":"BRIEF-BlinkLab Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2523930964","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523930964?lang=en_us&edition=fundamental","pubTime":"2025-03-31 10:10","pubTimestamp":1743387052,"startTime":"0","endTime":"0","summary":"BRIEF-BlinkLab Seeks Trading HaltMarch 31 (Reuters) - BlinkLab Ltd BB1.AX:SEEKS TRADING HALT PENDING ANNOUNCEMENT ON UPDATE REGARDING RECRUITMENT FOR FDA REGULATORY STUDYFurther company coverage: BB1.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QC05Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","BB1.AU"],"gpt_icon":0},{"id":"2523200987","title":"Blinklab - Seeks Trading Halt Pending Announcement on Update Regarding Recruitment for FDA Regulatory Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2523200987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523200987?lang=en_us&edition=fundamental","pubTime":"2025-03-31 07:19","pubTimestamp":1743376779,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250330:nFWN3QC05Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","BB1.AU"],"gpt_icon":0},{"id":"2523965719","title":"When Will BlinkLab Limited (ASX:BB1) Turn A Profit?","url":"https://stock-news.laohu8.com/highlight/detail?id=2523965719","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523965719?lang=en_us&edition=fundamental","pubTime":"2025-03-29 04:14","pubTimestamp":1743192885,"startTime":"0","endTime":"0","summary":"With the business potentially at an important milestone, we thought we'd take a closer look at BlinkLab Limited's...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-bb1/blinklab-shares/news/when-will-blinklab-limited-asxbb1-turn-a-profit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BB1.AU","BK7094"],"gpt_icon":0},{"id":"2518080444","title":"BlinkLab Completes First Patient Testing in Ohio Trial; Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518080444","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518080444?lang=en_us&edition=fundamental","pubTime":"2025-03-12 11:41","pubTimestamp":1741750878,"startTime":"0","endTime":"0","summary":"BlinkLab  completed testing of the first patient in its digital diagnostic trial for autism at PriMED Clinical Research in Ohio, according to a Wednesday filing with the Australian bourse.The study aims to validate the BlinkLab Dx1 neurological test as a diagnostic aid for clinicians in early assessment of developmental disorders, the filing said.PriMED, along with North Shore Pediatric Therapy in Chicago, will participate in the initial study with 100 participants, with data set to be released in the third quarter of the year, per the filing.Shares rose 7% in afternoon trade Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","BB1.AU"],"gpt_icon":0},{"id":"2514871860","title":"BlinkLab Limited's (ASX:BB1) Path To Profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2514871860","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514871860?lang=en_us&edition=fundamental","pubTime":"2025-02-27 04:34","pubTimestamp":1740602097,"startTime":"0","endTime":"0","summary":"We feel now is a pretty good time to analyse BlinkLab Limited's  business as it appears the company may be on the cusp of a considerable accomplishment. BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. The AU$34m market-cap company announced a latest loss of AU$1.8m on 30 June 2024 for its most recent financial year result. The most pressing concern for investors is BlinkLab's path to profitability – when will it breakeven?Below we will provide a high-level summary of the industry analysts’ expectations for the company.According to the 2 industry analysts covering BlinkLab, the consensus is that breakeven is near. They anticipate the company to incur a final loss in 2026, before generating positive profits of AU$1.7m in 2027. The company is therefore projected to breakeven around 2 years from now. How fast will the company have to grow each year in order to reach the breakeven point by 2027?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/blinklab-limiteds-asx-bb1-path-203457247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BB1.AU","BK7094"],"gpt_icon":0},{"id":"2510888372","title":"BlinkLab Says North Shore Pediatric Therapy Joins Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2510888372","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510888372?lang=en_us&edition=fundamental","pubTime":"2025-02-10 13:57","pubTimestamp":1739167046,"startTime":"0","endTime":"0","summary":"BlinkLab  said the North Shore Pediatric Therapy joined its US clinical study, and it is expected to enroll patients in the coming weeks, according to a Monday Australian bourse filing.As part of the US registrational study, North Shore's use of the ADOS-2 diagnostic tool will serve as a critical benchmark for standard-of-care comparisons, the filing said.North Shore, a provider of pediatric services, specializing in the evaluation and treatment of autism, is the second US-based site to join the 100-patient initial phase of the registrational study.The clinic also provides access to a diverse population of children throughout the Chicago area, ensuring the study reflects a broad range of backgrounds and developmental profiles.The firm's shares rose 8% on market close on Monday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","BB1.AU"],"gpt_icon":0},{"id":"2509449848","title":"ASX Midday Sector Update: Materials Sector Upbeat, Healthcare Stocks Struggle","url":"https://stock-news.laohu8.com/highlight/detail?id=2509449848","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509449848?lang=en_us&edition=fundamental","pubTime":"2025-02-05 10:38","pubTimestamp":1738723124,"startTime":"0","endTime":"0","summary":"Materials stocks rose almost 2% at midday Wednesday, leading a rally on the Australian bourse. Higher iron ore prices buoyed mining stocks after China announced retaliatory tariffs on US goods.Rio Tinto Group  is grappling with further iron ore shipment delays after Cyclones Taliah and Vince caused high seas off its Western Australian ports, according to multiple media reports, citing a company spokesperson. The company moved iron ore ships from Cape Lambert and Dampier ports to avoid dangerous wave conditions.On the flip side, healthcare was the only sector trading in the red, shedding a little over 1%.BlinkLab  said PriMED Clinical Research in Ohio became the first site to join the initial phase of the firm's US-based autism diagnostic registrational trial. Its shares rose 10% in recent trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","ARKG","BK7095","RIO.AU","BB1.AU","XAO.AU","BK7507","XJO.AU","BK7511","XKO.AU","BK4544","BK4588","BK7094","HCSG","BK4585"],"gpt_icon":0},{"id":"2509448073","title":"BlinkLab Brings First Clinical Site on Board for Autism Diagnostic Registrational Trial, Shares Rise 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509448073","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509448073?lang=en_us&edition=fundamental","pubTime":"2025-02-05 09:51","pubTimestamp":1738720299,"startTime":"0","endTime":"0","summary":"BlinkLab  said PriMED Clinical Research in Ohio became the first site to join the initial phase of the firm's US-based autism diagnostic registrational trial, according to a Wednesday Australian bourse filing.The site is expected to commence patient recruitment and testing for the 100-patient study in February.PriMED will use the overarching institutional review board approval BlinkLab secured for the clinical trial.The firm is seeking to start initiating partnerships with sixteen sites across the US.The firm's shares rose 10% in recent trading on Wednesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","BB1.AU"],"gpt_icon":0},{"id":"2508487989","title":"We're Not Very Worried About BlinkLab's (ASX:BB1) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2508487989","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508487989?lang=en_us&edition=fundamental","pubTime":"2025-02-04 07:32","pubTimestamp":1738625565,"startTime":"0","endTime":"0","summary":"We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-bb1/blinklab-shares/news/were-not-very-worried-about-blinklabs-asxbb1-cash-burn-rate-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BB1.AU","BK7094"],"gpt_icon":0},{"id":"2492917077","title":"BRIEF-BlinkLab Ltd Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2492917077","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492917077?lang=en_us&edition=fundamental","pubTime":"2024-12-18 08:06","pubTimestamp":1734480391,"startTime":"0","endTime":"0","summary":"Dec 18 (Reuters) - BlinkLab Ltd   :   * TRADING HALT   * TRADING HALT PENDING ANNOUNCEMENT ON FDA PRE SUBMISSION OUTCOMEFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BB1.AU","BK7094"],"gpt_icon":0},{"id":"2492917078","title":"Blinklab Ltd-Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2492917078","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492917078?lang=en_us&edition=fundamental","pubTime":"2024-12-18 08:05","pubTimestamp":1734480355,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nTUE6WN3T9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BB1.AU","BK7094"],"gpt_icon":0},{"id":"2483142363","title":"BRIEF-BlinkLab Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2483142363","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483142363?lang=en_us&edition=fundamental","pubTime":"2024-11-15 15:23","pubTimestamp":1731655427,"startTime":"0","endTime":"0","summary":"BRIEF-BlinkLab Seeks Trading HaltNov 15 (Reuters) - BlinkLab Ltd BB1.AX:TRADING HALT PENDING ANNOUNCEMENT ON AUTISM STUDY RESULTSSource text: ID:nASXc81njDFurther company coverage: BB1.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nFWN3ML1QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BB1.AU","BK7094"],"gpt_icon":0},{"id":"2483390067","title":"Blinklab Ltd - Trading Halt Pending Announcement on Autism Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483390067","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483390067?lang=en_us&edition=fundamental","pubTime":"2024-11-15 13:44","pubTimestamp":1731649450,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nFWN3ML1QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BB1.AU","BK7094"],"gpt_icon":0},{"id":"2483601600","title":"ASX Market Update: Index retreats as Min Res takes a dive | Novemebr 13, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2483601600","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483601600?lang=en_us&edition=fundamental","pubTime":"2024-11-13 10:25","pubTimestamp":1731464700,"startTime":"0","endTime":"0","summary":"The ASX200 has been down 1.1% at 8,162 points in afternoon trade.The Australian wage price index increased 3.5% YoY and only 0.8% in the September quarter. However, this was due to a distorting effect caused by the introduction of minimum wage increases a year ago.The Financials sector has been the worst performer, down, 1.7%, followed by Health Care, down, 1.4% and Telecommunication, down, 1%.Wisetech  has been up 0.5% despite the launch of a class action against the software solutions company. The plaintiffs allege the company failed to inform the market of expected shortfalls in earnings in August 2019.Mineral Resourceshas been down 5.3% on news it will temporarily mothball its Bald Hill lithium mine in WA. The move affects 300 jobs, as the ongoing slump in lithium prices continues to impact the industry.And BlinkLab has been down 8.2% on news it’s part of a Monash Uni-based study examining its tech’s ability to diagnose autism and ADHD.That’s market update we’ll see you again later","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-update-index-retreats-as-min-res-takes-a-dive-novemebr-13-2024-2024-11-13/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["MIN.AU","BB1.AU","BK7016","BK7504","BK7507","WTC.AU","BK7094","BK7503","BK7095"],"gpt_icon":0},{"id":"2483062772","title":"BlinkLab teams up with Monash to trial tech in autism, ADHD study","url":"https://stock-news.laohu8.com/highlight/detail?id=2483062772","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483062772?lang=en_us&edition=fundamental","pubTime":"2024-11-13 07:07","pubTimestamp":1731452820,"startTime":"0","endTime":"0","summary":"BlinkLab  has confirimed its involvement in a Monash Uni-based study examining its tech’s ability to diagnose autism and ADHD.BlinkLab offers software that analyses a child’s eye movements informed by research suggesting those with autism and ADHD display unique eye behaviours not witnessed in people without those conditions.BlinkLab now finds itself on a data-finding mission within the larger Monash MAGNET large cohort study which is trying to enrol 1,000 families with children diagnosed with either or both conditions. The uni’s Turner Institute is ultimately overseeing the program.“Using BlinkLab Dx 1, we aim to complete comprehensive deep sensory phenotyping of subjects with only autism, only ADHD, or with both autism and ADHD from the large MAGNET cohort,” the company wrote on Wednesday.BlinkLab – and heads at Turner and Monash – are trying to figure out if the company’s software can outperform other traditional diagnosis methods.Join the discussion: See what HotCopper users are sa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/blinklab-teams-up-with-monash-to-trial-tech-in-autism-adhd-study-2024-11-13/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK4139","BB1.AU","ABVC","BK7094","ADHD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BB1.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BB1.AU\",market:\"AU\",,,undefined,":[]}}